CFO Miln James Uses Rule‑10b5‑1 Plan to Sell 5,454 Xometry Shares, Hinting at Strategic Tax Moves Amid 28% Stock Decline.

Insider Selling on a Diminishing Stock: What the Numbers Tell Us

The latest Form 4 filed by Xometry Inc. on March 2, 2026 shows Chief Financial Officer Miln James liquidating 5,454 shares of Class A common stock through a Rule 10b5‑1 plan. The average sale price of $41.26 matches the market close, but the cumulative proceeds of roughly $224 k are modest against the CFO’s existing stake of 170 k shares. In a month when the stock has dipped 28 % from the prior close and remains 38 % below its 52‑week high, James’ decision to sell under a pre‑planned program signals confidence that the price will recover, but also highlights the liquidity needs or tax‑planning considerations that often drive such trades.

Implications for Investors and the Company’s Trajectory

James’ consistent use of a 10b5‑1 plan—evidenced by 12 separate sales in March and a prior buy of 54 k shares in late February—indicates a long‑term commitment to disciplined trading rather than opportunistic selling. For shareholders, this pattern reduces the risk of insider panic sales, yet it also underscores that the company’s top executives are not accumulating significant equity. Given Xometry’s negative earnings and a price‑to‑earnings ratio of –44.69, the CFO’s focus on tax‑efficient divestitures may reflect broader capital‑allocation pressures as the firm navigates an investment‑heavy growth phase.

Miln James: A Profile of Cautious Capital Management

Across the past 12 months, James has sold more than 20 k shares each month, with average sale prices oscillating between $40 and $57. His most recent 24‑month average sale price sits near $47, suggesting a steady valuation expectation. Unlike peers such as CEO Randolph Altschuler, who has made large block purchases, James has rarely increased his position, instead opting for systematic disposals. This disciplined approach is typical for CFOs who balance fiduciary duties with personal tax obligations and who prefer to avoid the perception of insider speculation.

What This Means for Xometry’s Future

The CFO’s trades are a small fraction of the company’s overall liquidity needs. Xometry’s valuation remains high relative to book value, and the stock’s negative earnings signal that profitability will likely materialize only after substantial scaling. If the CFO’s 10b5‑1 plan continues, it may signal that insiders expect a near‑term plateau in share price before a rebound—perhaps tied to the company’s upcoming investor conferences or a strategic product launch. For investors, the key takeaway is that insider selling here is procedural rather than predatory, but it also underscores the importance of monitoring future earnings guidance and the company’s cash burn rate before committing significant capital.

Bottom Line

Miln James’ recent sales are part of a steady, rule‑based program that reflects both personal tax strategy and a cautious stance on equity accumulation. For Xometry shareholders, the insider activity suggests that executives remain neither overly optimistic nor alarmist about the stock’s near‑term prospects. Investors should therefore focus on the company’s cash flow trajectory, product roadmap, and any forthcoming earnings announcements to gauge whether the current price, still below its 52‑week high, will begin to recover.